These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2012627)

  • 1. The effects of cyclosporin A on eicosanoid excretion in patients with rheumatoid arthritis.
    Weinblatt M; Helfgott S; Coblyn J; Spragg J; Uedelhoven WM; Tumeh S; Sperling R; Lorenz R; Maier A; Weber P
    Arthritis Rheum; 1991 Apr; 34(4):481-5. PubMed ID: 2012627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity.
    Benigni A; Chiabrando C; Piccinelli A; Perico N; Gavinelli M; Furci L; Patino O; Abbate M; Bertani T; Remuzzi G
    Kidney Int; 1988 Aug; 34(2):164-74. PubMed ID: 3184595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity.
    Coffman TM; Carr DR; Yarger WE; Klotman PE
    Transplantation; 1987 Feb; 43(2):282-5. PubMed ID: 3810836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity.
    Smith SR; Kubacki VB; Rakhit A; Martin LL; Schaffer AV; Jasani MK; Hefty DJ; Johnston T; Cannon C; Bennett WM
    Transplantation; 1993 Dec; 56(6):1422-6. PubMed ID: 8279014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of short-term administration of cromakalim on renal hemodynamics and eicosanoid excretion in essential hypertension.
    Lebel M; Grose JH; Lacourcière Y
    Am J Hypertens; 1991 Sep; 4(9):740-4. PubMed ID: 1834087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional renal effects of cyclosporin. Physiopathological mechanisms].
    Deray G; Martinez F; Cacoub P; Baumelou A; Jacobs C
    Nephrologie; 1988; 9(2):73-5. PubMed ID: 3050579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.
    Kontessis PS; Jones SL; Barrow SE; Stratton PD; Alessandrini P; De Cosmo S; Ritter JM; Viberti GC
    J Lab Clin Med; 1993 Mar; 121(3):415-23. PubMed ID: 8445289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of urinary thromboxane excretion to cyclosporine nephrotoxicity.
    Schnabel FR; Wait RB; Kahng KU
    Transplantation; 1991 Mar; 51(3):686-9. PubMed ID: 2006526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans.
    Weir MR; Klassen DK; Shen SY; Sullivan D; Buddemeyer EU; Handwerger BS
    Transplantation; 1990 Jan; 49(1):41-7. PubMed ID: 2301025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longterm cyclosporine therapy in rheumatoid arthritis.
    van Rijthoven AW; Dijkmans BA; Goei Thè HS; Boers M; Cats A
    J Rheumatol; 1991 Jan; 18(1):19-23. PubMed ID: 2023194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal eicosanoids and renal hemodynamics in early borderline hypertension.
    Lebel M; Grose JH
    Clin Invest Med; 1991 Dec; 14(6):525-34. PubMed ID: 1794206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sulindac and naproxen on prostaglandin excretion in patients with impaired renal function and rheumatoid arthritis.
    Eriksson LO; Sturfelt G; Thysell H; Wollheim FA
    Am J Med; 1990 Sep; 89(3):313-21. PubMed ID: 2203262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis.
    Nakamura H; Hishinuma T; Suzuki N; Chiba S; Tsukamoto H; Takabatake M; Sawai T; Mitomo T; Inoue H; Matsumoto F; Mizugaki M
    Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):301-6. PubMed ID: 11993724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine-induced renal dysfunction in human renal allograft recipients.
    Kiberd BA
    Transplantation; 1989 Dec; 48(6):965-9. PubMed ID: 2688208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of acute nephrotoxicity with low doses of cyclosporin: experimental study in the rat.
    Sabbatini M; De Nicola L; Uccello F; Russo D; Conte G; Dal Canton A; Andreucci VE
    Nephrol Dial Transplant; 1990; 5(1):69-74. PubMed ID: 2109287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in urinary thromboxane B2 in rats caused by cyclosporine.
    Kawaguchi A; Goldman MH; Shapiro R; Foegh ML; Ramwell PW; Lower RR
    Transplantation; 1985 Aug; 40(2):214-6. PubMed ID: 4024243
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of protein intake and unilateral nephrectomy on renal function and eicosanoid excretion in rats.
    De Keijzer MH; Provoost AP
    Miner Electrolyte Metab; 1992; 18(2-5):113-6. PubMed ID: 1465043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A in rheumatoid arthritis: preliminary clinical results of an open trial.
    Dougados M; Amor B
    Arthritis Rheum; 1987 Jan; 30(1):83-7. PubMed ID: 3545223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic cyclosporine administration on renal blood flow and intrarenal blood flow distribution.
    Youngelman DF; Kahng KU; Rosen BD; Dresner LS; Wait RB
    Transplantation; 1991 Feb; 51(2):503-9. PubMed ID: 1994546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A therapy in rheumatoid arthritis: only strict application of the guidelines for safe use can prevent irreversible renal function loss.
    van den Borne BE; Landewé RB; Goei The HS; Breedveld FC; Dijkmans BA
    Rheumatology (Oxford); 1999 Mar; 38(3):254-9. PubMed ID: 10325664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.